Occasional reinjection in the same spot typically causes no immediate harm, but repeated injections in identical locations lead to lipohypertrophyhardened fat deposits that reduce medication absorption and make future injections uncomfortable
GHK-Cu signals repair in the tissue surrounding the follicle
Recent studies have recognized the dual anti-inflammatory and glycemic control properties of teneligliptin, which imply that it may have additional benefits aside from glucose control [23]
Skin Support GHK-Cu is often discussed by patients interested in skin texture, elasticity, collagen support and a healthier-looking appearance
Watch this space, researchers say.
Jake Lombardo, Co-founder and CEO, Anodyne Nanotech, presented the preclinical data on the once-weekly GLP-1 patch at the 14th annual Partnerships in Drug Delivery (PODD2024) Conference in 2024